Description: Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Home Page: www.evelobio.com
EVLO Technical Analysis
620 Memorial Drive
Cambridge,
MA
02139
United States
Phone:
617 577 0300
Officers
Name | Title |
---|---|
Dr. Balkrishan Gill Ph.D. | Pres, CEO & Director |
Dr. Jonathan B. Zung Ph.D. | Chief Devel. Officer |
Ms. Marella Thorell | CFO & Treasurer |
Mr. Stephen J. Carriere | VP & Chief Accounting Officer |
Dr. Chun Zhang Ph.D. | Chief Technical Operations & Quality Officer |
Dr. Mark Bodmer Ph.D. | Chief Scientific Officer and Pres of R&D |
Ms. Kendra Sweeney | Head of Investor Relations & Capital Markets |
Ms. Jessica Cotrone | VP & Head of Communications |
Ms. Leslie Wardwell-Scott Ph.D. | VP and Head of Corp. Devel. & Strategic Integration |
Ms. Julie Carretero | Chief People Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Biotechnology |
GIC Sub-Industry: | Biotechnology |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 22.3128 |
Price-to-Sales TTM: | 0 |
IPO Date: | 2018-05-09 |
Fiscal Year End: | December |
Full Time Employees: | 122 |